Safranin O Staining Pellets were fixed overnight at 4C in 10% buffered formalin (Fisher Chemical, Hampton, NH, United States), dehydrated in gradient ethanol, cleared in xylene, and then embedded in paraffin
The blend is supplied strictly for in-vitro or preclinical study, labeled research use only, and is not intended to diagnose, treat, or prevent any condition
Single-mechanism drugs target one cytokine or one receptor
Lee YJ, Javdan B, Cowan A, Smith K
Published human trials report minimal adverse events at doses ranging from 50mg to 100mg daily over 12 weeks, with the most common findings being mild gastrointestinal discomfort (812% of participants) and transient headache (57%)